| Field | Specification |
|---|---|
| Mfr No | |
| Clonality | |
| Host | |
| Immunogen | A human partial recombinant protein (from within amino acids 200-323) was used as the immunogen for the AQP4 antibody. |
| Isotype | |
| Product Type | |
| Purity | |
| Reactivity | |
| Storage | |
| Target | |
| UniProt # |
Overview
AQP4 Antibody / Aquaporin 4 is an antibody targeting AQP4. Host: Mouse. Monoclonal. Clone: AQP4/3323. Format: Purified. Applications: FACS, IHC-P, WB.
Key elements and design rationale
- Target: AQP4.
- Immunogen: A human partial recombinant protein (from within amino acids 200-323) was used as the immunogen for the AQP4 antibody..
- Species reactivity: Human.
- Localization: Cell membrane, cytoplasm.
- Conjugate: Unconjugated (no label listed).
Biological background (from provided description)
Aquaporin 4 plays an important role in brain water homeostasis. [UniProt]
Common research applications
- WB: relative abundance and band pattern assessment using appropriate controls.
- IHC: tissue distribution assessment; interpret with matched controls.
Notes for experimental interpretation
- Account for isoforms, paralogs, and post-translational modifications when interpreting signal.
- Support specificity with biological controls (e.g., KO/KD where available) and technical controls (e.g., secondary-only/isotype).
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
